Elevance Health Inc.
Elevance Health Inc. (ELV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ELV · as of Jun 8, 2026
Key Statistics
Explore Elevance Health Inc. Data
elv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 37 · Buy rate: 73.0%
The ELV analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month price target is $413.31, representing -0.53% downside from the current price of $415.53.
Competitors & Peers
elv competitorsELV
BDX
CI
COR
CVS
GEHCStock Performance
Full HistoryAbout Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healt…
what is elevance health inc. · elv stock overview · elevance health inc. company profile · who is elevance health inc. ceo · elv NYSE · elevance health inc. headquarters · elevance health inc. business segments
About Stock Overview & Key Data
Elevance Health Inc. (ELV) is a Healthcare company in the Medical - Healthcare Plans industry, listed on NYSE since Oct 30, 2001. As of the latest trading session, ELV stock price is $415.53, with a market capitalization of $90.2B. The stock has returned +6.65% over the past 12 months and +18.54% year-to-date.
According to 37 Wall Street analysts, the consensus rating for Elevance Health Inc. stock is Buy, with an average 12-month price target of $413.31. In fiscal year 2025, Elevance Health Inc. reported revenue of $199.1B and net income of $5.7B. For detailed data — including Elevance Health Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Elevance Health Inc. (ELV) stock price is $415.53. The stock is traded on NYSE under the ticker symbol ELV. The 52-week range is $273.71 – $416.56.